Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yichen Liu

Showing results (241-250 of 318) with videos related to

Pageof 32
Sort By:
Materials Today. Bio|December 1, 2025
A bufalin and CRISPR/Cas9 ribonucleoprotein-loaded calcium lactate nanomedicine for pyroptosis/apoptosis and synergistic cancer immunotherapyYichen Liu, Dahai Hou, Hui Wang, et al.
Journal of Hazardous Materials|December 15, 2024
Association between air pollution and hospitalization for acute exacerbation of kidney failure: A nationwide time-stratified case-crossover study in ChinaYalan Xiao, Cong Liu, Yichen Liu, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast CancerZhenyan Hou, Songwen Lin, Tingting Du, et al.
Journal of Nanobiotechnology|October 11, 2025
Outer membrane vesicles-based nano-regulator for cancer immunotherapy by modulating neutrophils N1 polarization and hitchhiking deliveryXiaoning Liu, Qun Niu, Haoxiang Yang, et al.
Journal of Medicinal Chemistry|February 9, 2026
Design, Synthesis, and Mechanistic Evaluation of l-Theanine Derivatives Targeting Cathepsin D for Anti-Hepatic FibrosisMiao Lv, Simin Guo, Congying Huang, et al.
Pharmacogenomics|August 1, 2015
Hsa-miR-27a is involved in the regulation of CYP3A4 expression in human livers from Chinese Han populationYe Shi, Yichen Liu, Zhiyun Wei, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Correction: Hou et al. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. <i>Pharmaceuticals</i> 2023, <i>16</i>, 749Zhenyan Hou, Songwen Lin, Tingting Du, et al.
The American Journal of Chinese Medicine|June 16, 2024
The Role of Traditional Chinese Medicines in the Treatment of OsteoporosisLiang Wang, Xinyi Huang, Jinran Qin, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 6, 2024
Advancing Superconductivity with Interface EngineeringYichen Liu, Qingxiao Meng, Pezhman Mahmoudi, et al.
Cell Death and Differentiation|July 6, 2019
ATF3 promotes erastin-induced ferroptosis by suppressing system Xc<sup>.</sup>Liyuan Wang, Yichen Liu, Tingting Du, et al.
Pageof 32

Showing results (241-250 of 318) with videos related to

Sort By:
Pageof 32
Materials Today. Bio|December 1, 2025
A bufalin and CRISPR/Cas9 ribonucleoprotein-loaded calcium lactate nanomedicine for pyroptosis/apoptosis and synergistic cancer immunotherapyYichen Liu, Dahai Hou, Hui Wang, et al.
Journal of Hazardous Materials|December 15, 2024
Association between air pollution and hospitalization for acute exacerbation of kidney failure: A nationwide time-stratified case-crossover study in ChinaYalan Xiao, Cong Liu, Yichen Liu, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast CancerZhenyan Hou, Songwen Lin, Tingting Du, et al.
Journal of Nanobiotechnology|October 11, 2025
Outer membrane vesicles-based nano-regulator for cancer immunotherapy by modulating neutrophils N1 polarization and hitchhiking deliveryXiaoning Liu, Qun Niu, Haoxiang Yang, et al.
Journal of Medicinal Chemistry|February 9, 2026
Design, Synthesis, and Mechanistic Evaluation of l-Theanine Derivatives Targeting Cathepsin D for Anti-Hepatic FibrosisMiao Lv, Simin Guo, Congying Huang, et al.
Pharmacogenomics|August 1, 2015
Hsa-miR-27a is involved in the regulation of CYP3A4 expression in human livers from Chinese Han populationYe Shi, Yichen Liu, Zhiyun Wei, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Correction: Hou et al. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. <i>Pharmaceuticals</i> 2023, <i>16</i>, 749Zhenyan Hou, Songwen Lin, Tingting Du, et al.
The American Journal of Chinese Medicine|June 16, 2024
The Role of Traditional Chinese Medicines in the Treatment of OsteoporosisLiang Wang, Xinyi Huang, Jinran Qin, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 6, 2024
Advancing Superconductivity with Interface EngineeringYichen Liu, Qingxiao Meng, Pezhman Mahmoudi, et al.
Cell Death and Differentiation|July 6, 2019
ATF3 promotes erastin-induced ferroptosis by suppressing system Xc<sup>.</sup>Liyuan Wang, Yichen Liu, Tingting Du, et al.
Pageof 32